Troy A. Ignelzi

Chief Financial Officer

Chief Financial Officer at Rapport Therapeutics, Inc., filing insider transactions on 2026-10-21.

Total Purchases

$144K

1 transaction

Total Sales

—

0 transactions

Companies Traded

1 total filings

Active Since

2026-10-21

Last: 2026-10-21

Companies

Rapport Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-10-21	RAPP	Purchase	5,500	$26.10	$144K	15.5K	SEC ↗